Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnetic resonance elastography to predict cirrhosis complications under nucleos(t)ide analogue therapy
ChiCTR2000035780Phase 4Not yet recruiting
- Sponsor
- Shanghai Public Health Clinical Center
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of entecavir and tenofovir in Chronic Hepatitis B (CHB) and Cirrhosis (4 arms), sponsored by Shanghai Public Health Clinical Center. Primary endpoints: Liver stiffness and Incidence of complications. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
entecavirtenofovir
03
Conditions
Chronic Hepatitis B (CHB)Cirrhosis
Beyond the preview
Go deeper on ChiCTR2000035780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035780.